Maurizio Tonato

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Filippo de Marinis, Monica Rinaldi et al. · Journal of Clinical Oncology · 2002 · 890 citations

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini et al. · The Lancet Oncology · 2009 · 591 citations

Thrombosis, Medicine, Pharmacology +8

Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli et al. · JNCI Journal of the National Cancer Institute · 2004 · 367 citations · Full text

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Lucio Crinò, Giorgio V. Scagliotti, Serafino Ricci et al. · Journal of Clinical Oncology · 1999 · 366 citations

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

Lucio Crinò, Giorgio V. Scagliotti, M. Marangolo et al. · Journal of Clinical Oncology · 1997 · 306 citations